Skip to main content

MoneyWorks4Me

Lupin informs about press release

17 Feb 2023 Evaluate

Lupin has informed that it enclosed a press release as regards receipt of Establishment Inspection Report from the U.S. FDA for the Company’s new injectable facility located in Nagpur, India.

The above information is a part of company’s filings submitted to BSE.




Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..